Fundraising Fox

John McKearn

Ph.D. at RiverVest Venture Partners

About

Joined RiverVest during Fund II and developed a successful biopharma investment strategy with a focus on building out the firm's life sciences expertise.

Investments

Board seats

OncoResponse IncWugen, Inc.

As listed on the firm's website.

Colleagues at RiverVest Venture Partners